Skip to main content

Published locations for Atopic Dermatitis: Upadacitinib Effectiveness Maintained Through 76 weeks Among Adolescents

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Atopic Dermatitis: Upadacitinib Effectiveness Maintained Through 76 weeks Among Adolescents

User login

  • Reset your password
  • /content/atopic-dermatitis-upadacitinib-effectiveness-maintained-through-76-weeks-among-adolescents
  • /edermatologynews/article/271337/atopic-dermatitis/atopic-dermatitis-upadacitinib-effectiveness
  • /familypracticenews/article/271337/atopic-dermatitis/atopic-dermatitis-upadacitinib-effectiveness
  • /internalmedicinenews/article/271337/atopic-dermatitis/atopic-dermatitis-upadacitinib-effectiveness
  • /pediatricnews/article/271337/atopic-dermatitis/atopic-dermatitis-upadacitinib-effectiveness
  • /pediatrics/article/271337/atopic-dermatitis/atopic-dermatitis-upadacitinib-effectiveness-maintained
  • /internalmedicine/article/271337/atopic-dermatitis/atopic-dermatitis-upadacitinib-effectiveness
  • /dermatology/article/271337/atopic-dermatitis/atopic-dermatitis-upadacitinib-effectiveness-maintained
  • /familymedicine/article/271337/atopic-dermatitis/atopic-dermatitis-upadacitinib-effectiveness